Susceptibility patterns in Pseudomonas aeruginosa causing nosocomial infections
- PMID: 15330323
- DOI: 10.1179/joc.2004.16.3.264
Susceptibility patterns in Pseudomonas aeruginosa causing nosocomial infections
Abstract
Nosocomial infection caused by Pseudomonas aeruginosa has not been reported previously in the Gaza Strip. This study aims to determine the distribution of antimicrobial drug resistance in P. aeruginosa causing nosocomial infections. One hundred thirty-one P. aeruginosa isolates were collected from various nosocomial infection clinical samples. The study was conducted between April and October 2003. The results of this study reveal that the most common resistance was to ampicillin, followed by cephalexin. The most effective antimicrobial agents were meropenem and amikacin, respectively. The highest resistance to ciprofloxacin was found among ICU and surgery sections. The data analysis shows that no remarkable difference was reported with respect to previous admission and prior antimicrobial treatment for most antibiotics. The results of this study emphasize the need for constant monitoring of antimicrobial effectiveness to correctly guide empiric therapy and local intervention programs in an attempt to reduce antimicrobial resistance.
Similar articles
-
Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents.Infect Control Hosp Epidemiol. 2008 Aug;29(8):716-22. doi: 10.1086/589813. Infect Control Hosp Epidemiol. 2008. PMID: 18590455
-
Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.PLoS One. 2021 Nov 15;16(11):e0257272. doi: 10.1371/journal.pone.0257272. eCollection 2021. PLoS One. 2021. PMID: 34780494 Free PMC article.
-
Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics.Pak J Pharm Sci. 2008 Jul;21(3):311-5. Pak J Pharm Sci. 2008. PMID: 18614431
-
Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.Future Microbiol. 2015;10(10):1683-706. doi: 10.2217/fmb.15.48. Epub 2015 Oct 6. Future Microbiol. 2015. PMID: 26439366 Review.
-
Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.Pharmacotherapy. 2005 Oct;25(10):1353-64. doi: 10.1592/phco.2005.25.10.1353. Pharmacotherapy. 2005. PMID: 16185180 Review.
Cited by
-
Nosocomial bloodstream infection in a pediatric intensive care unit.Indian J Pediatr. 2008 Jan;75(1):25-30. doi: 10.1007/s12098-008-0002-0. Indian J Pediatr. 2008. PMID: 18245931
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous